Help
Subscribe


GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy

 20 January 2018

Advanced search
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

Lethal hospital bug cases rocket

A new strain of C. difficile is difficult to eradicate from the ward, causing an excess number of cases, as well as more severe cases that make patients very ill, reports the BBC.

News image

fiogf49gjkf04

Clostridium difficile is not resistant to treatment, but some cases are difficult to treat.

The strain seen at Stoke Mandeville hospital in England is related to one which has emerged in the USA and Canada.

The number of cases of a potentially lethal hospital infection has rocketed since the 1990s, figures show.

The Department of Health has revealed there were 44,488 cases of C. difficile in over 65s in England last year.

The BBC News reports that this was the first time mandatory surveillance of the diarrhoea-causing infection has been undertaken.

In the early 1990s there were about 1,000 cases a year, but by 2003 the total rose to 35,536, England, Wales and Northern Ireland data showed.

However, this was only collected on a voluntary basis so the true figure may have been higher.

These latest statistics have showed that C.difficile is nearly 7 times more common than MRSA, although the superbug is more deadly.

C. difficile cannot be destroyed by hand gels, whereas MRSA can
BBC News

The Office for National Statistics data has showed C.difficile was the underlying cause of 934 deaths in 2003, a similar number linked to MRSA.

The Department of Health also released figures for the number of cases of GRE, a bug which can cause wound infections and occasionally blood poisoning.”

Although hard to treat it is not particularly virulent compared to other hospital infections, with just 620 cases.

Chief nursing officer Christine Beasley said some of the rise in infections was down to better reporting.

”This is largely due to the fact that medical care advances were keeping people alive for longer, making them more susceptible to bugs.

"The immune system does not work as well and, therefore, people are more vulnerable.”

C. difficile will now be included in the government programme to fight MRSA.

C. difficile usually affects the elderly, although young people have been affected.

This infection can prove fatal if antibiotic treatment fails to kill all the spores in the gut.

It is also very difficult to eradicate from the ward environment, which means it is easy for other patients to become infected.

The spores of C. difficile cannot be destroyed by hand gels, whereas MRSA can.

Experts have said staff must use soap and water to get rid of the bug.

The BBC also reports that hospital wards must be cleaned using more powerful disinfectants than usual to eradicate the bug.

Professor Mark Willcox is a consultant medical microbiologist who works on a C. difficile standards group that reported to the Department of Health.

Professor Willcox told the BBC "The most worrying concern is not so much how many cases we are having, but this new strain which appeared first in Canada about 2 or 3 years ago.”

"It appears to cause an excess number of cases when it occurs in a hospital, but the particularly worrisome thing is that it causes more severe cases - patients can be very ill with this strain."

BBC News 2005, 26 August, 09:29 GMT
29 August 2005

Go to top of page Email this page Email this page to a colleague

 19 January 2018 
Ileoanal pouch microbiota
 19 January 2018 
Predicting the risk of early surgery in Crohn’s
 19 January 2018 
Lifestyle intervention vs gastric bypass for obesity and diabetes
 18 January 2018 
Sleeve gastrectomy vs Roux-en-Y gastric bypass
 18 January 2018 
Healthcare costs of liver cancer in the USA
 18 January 2018 
High-risk adenomas at colonoscopy
 17 January 2018 
“Weekend effect” in upper GI hemorrhage
 17 January 2018 
Gut dysbiosis and non-antibiotic prescription medications
 17 January 2018 
Reducing surgical infections in high-outlier colorectal unit
 16 January 2018 
Bundle of care in GI cancer surgery
 16 January 2018 
Anxiety about colonoscopy
 16 January 2018 
Thiopurines and colorectal neoplasia in IBD
 15 January 2018 
Risks of death after liver transplants for liver cancer
 15 January 2018 
Recent advances in hepatocellular carcinoma
 15 January 2018 
Ileostomy output using telemedicine
 12 January 2018 
Surveillance protocols after colorectal cancer resection
 12 January 2018 
Biologic therapy by pregnant women with IBD and infant vaccines
 12 January 2018 
Biologic therapies for IBD in the USA
 11 January 2018 
Genetic risk factors in GERD
 11 January 2018 
Predictor of colorectal adenoma
 11 January 2018 
Ectopic pregnancy in IBD 
 10 January 2018 
Fecal immunochemical tests for colorectal cancer screening
 10 January 2018 
Risk factors for advanced NAFLD
 10 January 2018 
Dyspepsia prevalence with gastroesophageal reflux–type symptoms
 09 January 2018 
Screening intervals for people with family histories of colorectal cancer
 09 January 2018 
Financial impact of colorectal cancer
 09 January 2018 
Current practice and future research in autoimmune hepatitis
 08 January 2018 
Reliability of the IBD index
 08 January 2018 
Improving prognosis in patients with primary sclerosing cholangitis
 08 January 2018 
Aprepitant and nausea with gastroparesis
 05 January 2018 
Autoimmune pancreatitis and IBD
 05 January 2018 
Primary nonresponse to infliximab therapy
 05 January 2018 
Anesthesia assistance in outpatient colonoscopy
 04 January 2018 
Dietary polyphenols in the etiology of IBD
 04 January 2018 
Yoga vs low-FODMAP in IBS
 04 January 2018 
Local esophageal food allergen injections in eosinophilic esophagitis
 03 January 2018 
Population health management for IBD
 03 January 2018 
GERD in asthma and COPD
 03 January 2018 
Critical research gaps in colorectal cancer
 22 December 2017 
Costs of extrahepatic manifestations of Hep C
 22 December 2017 
Cholera vaccine and risk of death in colorectal cancer
 22 December 2017 
Colonoscopy after colorectal cancer resection
 21 December 2017 
Human oral microbiome and pancreatic cancer risk
 21 December 2017 
Health management for IBD
 21 December 2017 
PPI and Alzheimer's disease
 20 December 2017 
Management of abnormal liver blood tests
 20 December 2017 
Incidence of biopsy-verified celiac disease
 20 December 2017 
Osteoporotic fractures in Barrett's esophagus
 19 December 2017 
Alcohol abstinence and alcoholic hepatitis
 19 December 2017 
Family burden of pediatric Crohn's in the USA
 19 December 2017 
Early readmission in IBD patients
 18 December 2017 
Colorectal cancer mortality with low-risk adenomas at colonoscopy
 18 December 2017 
Disease activity indices in celiac disease
 18 December 2017 
Smoking behaviour predicted the risk of surgery in Crohn's
 15 December 2017 
Molecular classification of Crohn's disease
 15 December 2017 
Medical cannabinoid legalization policy and vomiting
 15 December 2017 
Inflammatory diet pattern and colorectal cancer risk
 14 December 2017 
PPIs and gastric cancer after H.pylori eradication
 14 December 2017 
H. pylori eradication therapies in countries with clarithromycin resistance
 13 December 2017 
Disease severity in NAFLD

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2018 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us